FDA Clearance Tracker · DEN240023
SmartFlow Neuro Cannula
Last checked: Nov 20, 2026Latest source record: Nov 13, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 13, 2024
De Novo granted
Time to decision
175 days
Received May 22, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN240023
- Device name
- SmartFlow Neuro Cannula
- Applicant
- ClearPoint Neuro, Inc.
- Applicant location
- Solana Beach, CA
- Received
- May 22, 2024
- Decided
- Nov 13, 2024
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.4110
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN240023
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for ClearPoint Neuro, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243657 · Decided Jan 24, 2025 · 58 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
- Bone Anchor (NGS-BA-01)510(k)
K233703 · Decided Apr 26, 2024 · 161 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
- SmartFrame OR510(k)
K233141 · Decided Jan 12, 2024 · 107 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.